309 related articles for article (PubMed ID: 22464773)
1. Exercise oscillatory breathing and NT-proBNP levels in stable heart failure provide the strongest prediction of cardiac outcome when combining biomarkers with cardiopulmonary exercise testing.
Guazzi M; Boracchi P; Labate V; Arena R; Reina G
J Card Fail; 2012 Apr; 18(4):313-20. PubMed ID: 22464773
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of a new cardiopulmonary exercise testing parameter in chronic heart failure: oxygen uptake efficiency at peak exercise - comparison with oxygen uptake efficiency slope.
Toste A; Soares R; Feliciano J; Andreozzi V; Silva S; Abreu A; Ramos R; Santos N; Ferreira L; Ferreira RC
Rev Port Cardiol; 2011 Oct; 30(10):781-7. PubMed ID: 22118129
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of NT-proBNP at rest and peak exercise in patients with impaired left ventricular function.
Kallistratos MS; Pavlidis AN; Chamodraka ES; Varounis C; Dritsas A; Laoutaris ID; Manolis AJ; Cokkinos DV
Angiology; 2012 Oct; 63(7):516-21. PubMed ID: 22156406
[TBL] [Abstract][Full Text] [Related]
4. Natriuretic peptides for the prediction of severely impaired peak VO2 in patients with lung disease.
Maeder MT; Brutsche MH; Christ A; Reichlin T; Staub D; Noveanu M; Breidthardt T; Potocki M; Mueller C
Respir Med; 2009 Sep; 103(9):1337-45. PubMed ID: 19375295
[TBL] [Abstract][Full Text] [Related]
5. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.
Rengo G; Pagano G; Parisi V; Femminella GD; de Lucia C; Liccardo D; Cannavo A; Zincarelli C; Komici K; Paolillo S; Fusco F; Koch WJ; Perrone Filardi P; Ferrara N; Leosco D
Int J Cardiol; 2014 Feb; 171(3):384-9. PubMed ID: 24388546
[TBL] [Abstract][Full Text] [Related]
6. Cardiopulmonary exercise testing and prognosis in heart failure due to systolic left ventricular dysfunction: a validation study of the European Society of Cardiology Guidelines and Recommendations (2008) and further developments.
Corrà U; Giordano A; Mezzani A; Gnemmi M; Pistono M; Caruso R; Giannuzzi P
Eur J Prev Cardiol; 2012 Feb; 19(1):32-40. PubMed ID: 21450614
[TBL] [Abstract][Full Text] [Related]
7. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2).
Francis DP; Shamim W; Davies LC; Piepoli MF; Ponikowski P; Anker SD; Coats AJ
Eur Heart J; 2000 Jan; 21(2):154-61. PubMed ID: 10637089
[TBL] [Abstract][Full Text] [Related]
8. N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study.
Felker GM; Whellan D; Kraus WE; Clare R; Zannad F; Donahue M; Adams K; McKelvie R; Piña IL; O'Connor CM;
Am Heart J; 2009 Oct; 158(4 Suppl):S37-44. PubMed ID: 19782787
[TBL] [Abstract][Full Text] [Related]
9. Exercise ventilation inefficiency and cardiovascular mortality in heart failure: the critical independent prognostic value of the arterial CO2 partial pressure.
Guazzi M; Reina G; Tumminello G; Guazzi MD
Eur Heart J; 2005 Mar; 26(5):472-80. PubMed ID: 15618042
[TBL] [Abstract][Full Text] [Related]
10. The role of NT-proBNP in explaining the variance in anaerobic threshold and VE/VCO(2) slope.
Athanasopoulos LV; Dritsas A; Doll HA; Cokkinos DV
J Cardiopulm Rehabil Prev; 2011; 31(5):316-21. PubMed ID: 21908983
[TBL] [Abstract][Full Text] [Related]
11. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
12. Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights.
Guazzi M; Dickstein K; Vicenzi M; Arena R
Circ Heart Fail; 2009 Nov; 2(6):549-55. PubMed ID: 19919979
[TBL] [Abstract][Full Text] [Related]
13. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
[TBL] [Abstract][Full Text] [Related]
14. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.
Bettencourt P; Azevedo A; Pimenta J; Friões F; Ferreira S; Ferreira A
Circulation; 2004 Oct; 110(15):2168-74. PubMed ID: 15451800
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial).
Masson S; Latini R; Anand IS; Barlera S; Angelici L; Vago T; Tognoni G; Cohn JN;
J Am Coll Cardiol; 2008 Sep; 52(12):997-1003. PubMed ID: 18786480
[TBL] [Abstract][Full Text] [Related]
16. Development of a cardiopulmonary exercise prognostic score for optimizing risk stratification in heart failure: the (P)e(R)i(O)dic (B)reathing during (E)xercise (PROBE) study.
Guazzi M; Boracchi P; Arena R; Myers J; Vicenzi M; Peberdy MA; Bensimhon D; Chase P; Reina G
J Card Fail; 2010 Oct; 16(10):799-805. PubMed ID: 20932461
[TBL] [Abstract][Full Text] [Related]
17. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
[TBL] [Abstract][Full Text] [Related]
18. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure.
de Groote P; Dagorn J; Soudan B; Lamblin N; McFadden E; Bauters C
J Am Coll Cardiol; 2004 May; 43(9):1584-9. PubMed ID: 15120815
[TBL] [Abstract][Full Text] [Related]
19. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
20. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
